BRIEF published on 03/27/2025 at 07:35, 7 days 4 hours ago MaaT Pharma announces a capital increase of 13 million euros and 2024 annual results Financial Results Biotechnology Capital Increase MaaT013 AGvH
BRIEF published on 01/21/2025 at 18:05, 2 months 12 days ago Positive Results for MaaT033 Clinical Trial Biotechnology Security Oncology Clinical Trial MaaT033
PRESS RELEASE published on 12/10/2024 at 02:30, 3 months 24 days ago Inside Information / Other news releases
BRIEF published on 10/15/2024 at 07:35, 5 months 19 days ago MaaT Pharma Clinical Trial Recruitment Concluded Clinical Trial MaaT Pharma MaaT013 DSMB Notice AGvH Treatment
PRESS RELEASE published on 10/15/2024 at 07:30, 5 months 19 days ago Inside Information / Other news releases MaaT Pharma completes recruitment of its ARES Phase 3 Trial for MaaT013, a treatment for Acute Graft-versus-Host Disease, with topline results expected in January 2025 Clinical Trial MaaT Pharma MaaT013 ARES Phase 3 Trial Acute Graft-versus-Host Disease
BRIEF published on 09/04/2024 at 07:35, 6 months 29 days ago MaaT Pharma Announces Participation in Investor and Medical Conferences in September Investors Cancers Medical Conference MET Therapies Cell Transplantation
BRIEF published on 05/15/2024 at 07:35, 10 months 19 days ago MaaT Pharma successfully completes a fundraising of 19.2 million euros Biotechnology Fundraising Investment MaaT Pharma Clinical Tests
PRESS RELEASE published on 05/15/2024 at 07:30, 10 months 19 days ago Inside Information / News release on accounts, results MaaT Pharma announces successful completion of 19.2 million euros Global Offering with new shares, aims to fund R&D activities, Phase 3 trials, and broaden pipeline Biotechnology Fundraising Clinical Trials Global Offering MaaT Pharma
BRIEF published on 05/14/2024 at 19:39, 10 months 19 days ago MaaT Pharma Announces 18 Million Euro Global Offering and Strategic Developments Financial Strategy Phase 3 Trial Clinical-stage Biotechnology Global Offering Microbiome Ecosystem Therapies
PRESS RELEASE published on 05/14/2024 at 19:34, 10 months 19 days ago Inside Information / News release on accounts, results MaaT Pharma launches a global offering of approximately 18 million euros to fund R&D activities and expand shareholder base. Current shareholders commit to significant subscriptions Global Offering MaaT Pharma 18 Million Euros R&D Activities Shareholder Commitments
Published on 04/03/2025 at 11:00, 45 minutes ago Focus Graphite Advanced Materials Initiates Validation Testing of Lac Knife Anode Materials with Leading Battery Innovator C4V
Published on 04/03/2025 at 05:10, 6 hours 35 minutes ago Battery X Metals Announces Corporate Awareness Agreement
Published on 04/03/2025 at 01:35, 10 hours 10 minutes ago GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 12 hours 10 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 15 hours 45 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/03/2025 at 09:00, 2 hours 45 minutes ago Partners Group to invest in Gestcompost, the largest organic waste manager in Spain, through a continuation fund
Published on 04/03/2025 at 09:00, 2 hours 45 minutes ago Upward trends in Europe – growing investor interest?
Published on 04/03/2025 at 08:30, 3 hours 15 minutes ago ALVAREZ & MARSAL CREATES LEADING CORPORATE FINANCE PRACTICE IN SWITZERLAND BY JOINING FORCES WITH AVELA CAPITAL LED BY STEPHAN BRÜCHER
Published on 04/03/2025 at 08:15, 3 hours 30 minutes ago 'CGTN: China-India ties at 75: 'Dragon-Elephant Tango' will benefit both'
Published on 04/03/2025 at 09:45, 1 hour 59 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 31/03/2025
Published on 04/03/2025 at 09:35, 2 hours 10 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2025
Published on 04/03/2025 at 08:00, 3 hours 45 minutes ago Availability of preparatory documents for the Annual Shareholders’ Meeting of OPmobility SE
Published on 04/03/2025 at 00:37, 11 hours 8 minutes ago Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
